Hong Kong (HSI) Growth Pharmaceuticals & Biotech Stocks

UPDATED Feb 15, 2025

Discover Hong Kong Pharmaceuticals & Biotech Growth Stocks that are on the HSI. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

104 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
6185
CanSino Biologics
HK$32.909.3%89.7%HK$12.1bHK$32.68PS10.1xE128.6%0%
1548
Genscript Biotech
HK$11.9810.9%-14.3%HK$25.7bHK$22.72PS3.3xE111.3%0%
1477
Ocumension Therapeutics
HK$4.191.0%-16.7%HK$3.4bHK$8.35PS10.3xE97.2%n/a
2228
XtalPi Holdings
HK$6.6111.8%n/aHK$22.5bHK$8.58PS106.5xE90.7%n/a
1952
Everest Medicines
HK$37.30-7.6%115.6%HK$12.0bHK$37.83PS26.8xE90.1%n/a
2096
Simcere Pharmaceutical Group
HK$7.003.9%26.8%HK$17.3bHK$9.08PS2.6xE71.6%2.4%
1521
Frontage Holdings
HK$1.49-10.2%-19.0%HK$3.0bHK$1.12PE63.5xE67.7%n/a
2563
Beijing Biostar Pharmaceuticals
HK$15.40-0.6%n/aHK$5.6bHK$35.84PS78.5xE57.6%n/a
6855
Ascentage Pharma Group International
HK$35.40-4.6%42.5%HK$12.0bHK$51.15PS12.4xE53.7%n/a
9995
RemeGen
HK$15.628.0%-19.7%HK$14.4bHK$25.04PS5.1xE51.9%n/a
9966
Alphamab Oncology
HK$3.9910.2%-12.3%HK$3.8bHK$4.34PS14xE50.4%n/a
2480
Beijing Luzhu Biotechnology
HK$21.90-9.5%-21.8%HK$4.4bHK$30.65PB4.3xE50.4%n/a
2616
CStone Pharmaceuticals
HK$2.7014.4%75.3%HK$3.4bHK$2.51PS7xE49.9%n/a
2487
Cutia Therapeutics
HK$5.9721.3%-10.8%HK$1.9bHK$14.61PS8.9xE49.4%n/a
1877
Shanghai Junshi Biosciences
HK$12.528.5%3.0%HK$25.9bHK$15.53PS6.4xE47.4%n/a
2179
Jiangsu Recbio Technology
HK$9.1112.6%7.4%HK$4.4bHK$13.00PS93.7xE45.0%n/a
1801
Innovent Biologics
HK$37.503.4%-6.5%HK$61.4bHK$53.35PS7.7xE44.0%n/a
9926
Akeso
HK$60.20-7.3%37.1%HK$54.0bHK$76.10PS26.9xE43.8%n/a
2171
CARsgen Therapeutics Holdings
HK$10.209.2%107.7%HK$5.6bHK$10.24PS823.1xE27.6%n/a
9969
InnoCare Pharma
HK$6.5414.1%24.3%HK$13.4bHK$8.43PS11.9xE27.3%n/a
2268
WuXi XDC Cayman
HK$30.05-2.1%107.0%HK$36.0bHK$36.43PE56.4xE26.9%n/a
867
China Medical System Holdings
HK$7.721.7%-35.9%HK$18.7bHK$11.00PE12.5xE21.4%5.4%
1672
Ascletis Pharma
HK$4.02-4.1%118.5%HK$3.9bHK$3.94PS357.7xE20.1%n/a
6826
Shanghai Haohai Biological Technology
HK$26.302.9%3.7%HK$13.2bHK$42.57PE13.1xE16.8%3.3%
Page 1 of 5